• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Introduction to 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester (CAS No. 527681-12-5)

1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester (CAS No. 527681-12-5) is a unique and versatile compound that has garnered significant attention in the fields of organic chemistry and medicinal research. This compound is characterized by its distinct structural features and potential applications in various scientific and pharmaceutical domains. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements associated with this compound.

The molecular formula of 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester is C₁₀H₉NO₄, and its molecular weight is approximately 203.18 g/mol. The compound is a white crystalline solid at room temperature and exhibits good solubility in common organic solvents such as methanol and dimethyl sulfoxide (DMSO). Its chemical structure includes a pyridine ring fused with a dioxin moiety, which imparts unique electronic and steric properties that contribute to its reactivity and biological activity.

The synthesis of 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester can be achieved through various routes. One common method involves the reaction of 7-hydroxypyridine-2(1H)-one with dimethyl carbonate in the presence of a base such as potassium carbonate. This reaction proceeds via a nucleophilic substitution mechanism, leading to the formation of the desired methyl ester. Another approach involves the condensation of 7-formylpyridine-2(1H)-one with dimethyl carbonate followed by cyclization to form the dioxin ring. These synthetic methods have been optimized to achieve high yields and purity levels, making the compound readily available for further research and development.

In terms of biological activity, 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester has shown promising results in several areas. Recent studies have demonstrated its potential as an inhibitor of specific enzymes involved in various metabolic pathways. For instance, it has been reported to exhibit potent inhibitory activity against phosphodiesterase (PDE) enzymes, which play crucial roles in regulating cyclic nucleotide levels in cells. This property makes it a potential candidate for the development of new therapeutic agents for conditions such as cardiovascular diseases and neurological disorders.

Furthermore, 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester has been investigated for its anti-inflammatory properties. In vitro studies have shown that it can effectively reduce the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in activated immune cells. These findings suggest that the compound may have therapeutic potential in treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The pharmacokinetic properties of 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester have also been studied to evaluate its suitability for drug development. Preclinical studies have demonstrated that it exhibits favorable absorption profiles when administered orally or intravenously. Additionally, the compound shows good stability in plasma and tissues, which is essential for maintaining therapeutic concentrations over extended periods. These pharmacokinetic characteristics make it an attractive candidate for further clinical evaluation.

In conclusion, 1,4-Dioxino[2,3-c]pyridine-7-carboxylic acid, 2,3-dihydro-, methyl ester (CAS No. 527681-12-5) is a multifaceted compound with significant potential in both basic research and pharmaceutical applications. Its unique chemical structure and biological activities make it a valuable tool for exploring new therapeutic avenues. Ongoing research continues to uncover new insights into its mechanisms of action and potential uses in medicine. As more studies are conducted and new data become available, it is likely that this compound will play an increasingly important role in advancing our understanding of various biological processes and developing innovative treatments for human diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)